Colony Stimulating factor 1 receptor (CSF1R), also named as macrophage colony-stimulating factor receptor (M-CSFR) and CD115, is a single pass type I membrane protein and functions as receptor for the cytokine of colony stimulating factor 1 (CSF1), the interaction of both molecules controls the production, differentiation and function of macrophages, and is also involved in the development and carcinogenesis of the mammary gland. Mutations in CSF1R are also associated with CML and type M4 AML. The identification of CSF1R as drug target has led to repaid development of the inhibitor of CSF1R in the treatment of cancer or inflammatory diseases, such as Pexidartinib, PLX7486, ARRY-382, JNJ-40346527, BLZ945, Emactuzumab, AMG820, IMC-CS4 and cabiralizumab.
Ba/F3 cell, a murine interleukin-3 dependent pro-B cell line, is a popular system for exploring both kinases and their inhibitors, because some protein kinases can render the Ba/F3 cells to be depended on the activation of the kinases instead of IL-3 supplement, while their inhibitors can antagonize the kinase-dependent growth effects.